Dec 9 (Reuters) – The U.S. Food and Drug Administration said on Tuesday it had approved the first gene therapy for a rare and life-threatening immune disorder.
(Reporting by Sahil Pandey in Bengaluru; Editing by Maju Samuel)
FDA approves first gene therapy for rare immune disorder
Dec 9, 2025 | 5:23 PM
Comments